Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.45
Delayed Data
As of Apr 24
 +0.08 / +1.09%
Today’s Change
3.71
Today|||52-Week Range
13.88
+63.38%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close7.37
Today’s open7.31
Day’s range7.05 - 7.59
Volume92,845
Average volume (3 months)307,239
Market cap$80.6M
Dividend yield--
Data as of 4:00pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-5.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.62

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...-0.13-7.47%
MSTXMast Therapeutics In...+0.01+1.03%
AQXPAquinox Pharmaceutic...-0.03-0.38%
VCELVericel Corp-0.06-1.54%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$5.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers